Compare NeoGenomics Inc. Common Stock (NEO) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Palo Alto Networks Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Palo Alto Networks Inc trades at $368.68 (market cap $306.78B). The key difference: Palo Alto Networks Inc is far larger — about 141.4× NeoGenomics Inc. Common Stock's market cap, and Palo Alto Networks Inc is more actively traded (7,147,609 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Palo Alto Networks Inc for 82 Days on average.
| NEO | PANW | |
|---|---|---|
Market Cap | $2.17B | $306.78B |
Volume | 1,615,943 | 7,147,609 |
Sector | Health | Technology |
52-Week High | $19.91 | $419.91 |
52-Week Low | $7.19 | $141.67 |
Typical Hold Time | 0 Days | 82 Days |
Enterprise Value | $2.47B | $306.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Palo Alto Networks (PANW) trades at $397.03, down 1.68% on the day but near its 52-week high, with a bullish technical signal from moving averages. The company reported strong revenue growth to $9.22B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent news highlights AI-driven cybersecurity demand boosting sentiment, with a consensus analyst price target of $400.05.
Outlook remains positive due to AI security tailwinds and platformization strategy, but high valuation multiples (P/E 992.58) and rising costs pose risks. Earnings growth and market positioning support upside, though investors should weigh premium pricing against competitive and execution challenges in the cybersecurity sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
